Latent transforming growth factor-β binding proteins (LTBPs) - Structural extracellular matrix proteins for targeting TGF-β action

Cytokine and Growth Factor Reviews

Volumn 10, Issue 2, 1999, Pages 99-117

  Saharinen, Juha ^a   Hyytiäinen, Marko ^a   Taipale, Jussi ^a   Keski Oja, Jorma ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Fibrillins; Growth factor targeting activation; LTBP; Microfibrils; TGF

Indexed keywords

ACTIN BINDING PROTEIN; BINDING PROTEIN; CARRIER PROTEIN; CYSTEINE; EPIDERMAL GROWTH FACTOR; FIBRILLIN; LTBP-2 PROTEIN; LTBP-4 PROTEIN; SCLEROPROTEIN; TGF-BETA1 BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ANIMAL; CELL GROWTH; CHEMISTRY; CHEMOTAXIS; EXTRACELLULAR MATRIX; GENETICS; HUMAN; MARFAN SYNDROME; METABOLISM; MOLECULAR GENETICS; MOUSE; MULTIGENE FAMILY; NONHUMAN; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SECRETION;

EID: 0344721500     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(99)00010-6     Document Type: Short Survey

References (207)

1. Kingsley D. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:1994;133-146.
2. Roberts A., Sporn M. Transforming growth factor-β Clark R. The molecular and cellular biology of wound repair. 1996;275-308 Plenum Press, New York.
3. Derynck R., Jarrett J., Chen E., Eaton D., Bell J., Assoian R., Roberts A., Spom M., Goeddel D. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature. 316:1985;701-705.
4. de Martin R., Haendler B., Hofer-Warbinek R., Gaugitsch H., Wrann M., Schlusener H., Seifert J., Bodmer S., Fontana A., Hofer E. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J. 6:1987;3673-3677.
5. Hanks S., Armour R., Baldwin J., Maldonado F., Spiess J., Holley R. Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci. 85:1988;79-82.
6. Derynck R., Lindquist P., Lee A., Wen D., Tamm J., Graycar J., Rhee L., Mason A., Miller D., Coffey R., et al. A new type of transforming growth factor-β, TGF-β 3. EMBO J. 7:1988;3737-3743.
7. ten Dijke P., Hansen P., Iwata K., Pieler C., Foulkes J. Identification of another member of the transforming growth factor type β gene family. Proc Natl Acad Sci USA. 85:1988;4715-4719.
8. Jakowlew S., Dillard P., Sporn M., Roberts A. Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor β4 from chicken embryo chondrocytes. Mol Endocrinol. 2:1988;1186-1195.
9. Kondaiah P., Sands M., Smith J., Fields A., Roberts A., Sporn M., Melton D. Identification of a novel transforming growth factor-β (TGF-β5) mRNA in Xenopus Iaevis. J Biol Chem. 265:1990;1089-1093.
10. Massague J. The transforming growth factor-β family. Annu Rev Cell Biol. 6:1990;597-641.
11. Laiho M., Keski-Oja J. Transforming growth factor-βs as regulators of cellular growth and phenotype. Crit Rev Oncog. 3:1992;1-26.
12. Lawrence D. Transforming growth factor-β: a general review. Eur Cytokine Netw. 7:1996;363-374.
13. Moses H., Serra R. Regulation of differentiation by TGF-β Curr Opin Genet Dev. 6:1996;581-586.
14. Leof E., Proper J., Goustin A., Shipley G., DiCorleto P., Moses H. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci USA. 83:1986;2453-2457.
15. Pertovaara L., Saksela O., Alitalo K. Enhanced bFGF gene expression in response to transforming growth factor-β stimulation of AKR-2B cells. Growth Factors. 9:1993;81-86.
16. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., Alitalo K. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem. 269:1994;6271-6274.
17. Kay E., Lee M., Seong G., Lee Y. TGF-βs stimulate cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts. Curr Eye Res. 17:1998;286-293.
18. McCartney-Francis N., Wahl S. Transforming growth factor β: a matter of life and death. J Leukoc Bio. 55:1994;401-409.
19. Shull M., Ormsby I., Kier A., Pawlowski S., Diebold R., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
20. Kulkarni A., Huh C., Becker D., Geiser A., Lyght M., Flanders K., Roberts A., Sporn M., Ward J., Karlsson S. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA. 90:1993;770-774.
21. Diebold R., Eis M., Yin M., Ormsby I., Boivin G., Darrow B., Saffitz J., Doetschman T. Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated. Proc Natl Acad Sci USA. 92:1995.
22. Boivin G, O'Toole B, Ormsby I, Diebold R, Eis M, Doetschman T, Kier A. Onset and progression of pathological lesions in transforming growth factor-β1-deficient mice. Am J Pathol 1999;146:276-288.
23. Kaartinen V., Voncken J., Shuler C., Warburton D., Bu D., Heisterkamp N., Groffen J. Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nat Genet. 11:1995;415-421.
24. Sanford L., Ormsby I., Gittenberger-de Groot A., Sariola H., Friedman R., Boivin G., Cardell E., Doetschman T. TGF-β2 knockout mice have multiple developmental defects that are non-overlapping with other TGF-β knockout phenotypes. Development. 124:1997;2659-2670.
25. Taipale J., Saharinen J., Keski-Oja J. Extracellular matrix-associated transforming growth factor-β: role in cancer cell growth and invasion. Adv Cancer Res. 75:1998;87-134.
26. Borsi L., Castellani P., Risso A., Leprini A., Zardi L. Transforming growth factor-β regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett. 261:1990;175-178.
27. Bassols A., Massague J. Transforming growth factor-β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem. 263:1988;3039-3045.
28. O'Kane S., Ferguson M. Transforming growth factor-βs and wound healing. Int J Biochem Cell Biol. 29:1997;63-78.
29. Bottinger E., Kopp J. Lessons from TGF-β transgenic mice. Miner Electrolyte Metab. 24:1998;154-160.
30. Border W., Noble N. Transforming growth factor-β in tissue fibrosis. N Engl J Med. 331:1994;1286-1292.
31. Taipale J., Koli K., Keski-Oja J. Release of transforming growth factor-β1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem. 267:1992;25,378-25,384.
32. Taipale J., Lohi J., Saharinen J., Kovanen P.T., Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem. 259:1995;4689-4696.
33. Streuli C., Schmidhauser C., Kobrin M., Bissell M., Derynck R. Extracellular matrix regulates expression of the TGF-β1 gene. J Cell Biol. 120:1993;253-260.
34. Lawrence D., Pircher R., Kryceve-Martinerie C., Jullien P. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol. 121:1984;184-188.
35. Gentry L.E., Lioubin M.N., Purchio A.F., Marquardt H. Molecular events in the processing of recombinant type I pre-pro-transforming growth factor β to the mature polypeptide. Mol Cell Biol. 8:1988;4162-4168.
36. Gray A., Mason A. Requirement for activin A and transforming growth factor-β1 pro-regions in homodimer assembly. Science. 247:1990;1328-1330.
37. Dubois C.M., Laprise M.H., Blanchette F., Gentry L.E., Leduc R. Processing of transforming growth factor-β1 precursor by human furin convertase. J Biol Chem. 270:1995;10,618-10,624.
38. Gentry L.E., Nash B.W. The pro domain of pre-pro-transforming growth factor-β1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry. 29:1990;6851-6857.
39. McMahon G.A., Dignam J.D., Gentry L.E. Structural characterization of the latent complex between transforming growth factor β1 and β1-latency-associated peptide. Biochem J. 313:1996;343-351.
40. Miller D.M., Ogawa Y., Iwata K.K., ten Dijke P., Purchio A.F., Soloff M.S., Gentry L.E. Characterization of the binding of transforming growth factor-β1, -β2, and -β3 to recombinant β1-latency-associated peptide. Mol Endocrinol. 6:1992;694-702.
41. Miyazono K., Hellman U., Wernstedt C., Heldin C. Latent high molecular weight complex of transforming growth factor-β1. Purification from human platelets and structural characterization. J Biol Chem. 263:1988;6407-6415.
42. Wakefield L., Smith D., Flanders K., Sporn M. Latent transforming growth factor-β from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem. 263:1988;7646-7654.
43. Kanzaki T, Olofsson A, Moren A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin CH, TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences, Cell 61:1051-1061.
44. Tsuji T., Okada F., Yamaguchi K., Nakamura T. Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues. Proc Natl Acad Sci USA. 87:1990;8835-8839.
45. Taipale J., Miyazono K., Heldin C.H., Keski-Oja K. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol. 124:1994;171-181.
46. Dallas S.L., Park-Snyder S., Miyazono K., Twardzik D., Mundy G.R., Bonewald L.F. Characterization and autoregulation of latent transforming growth factor-β (TGF-β) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF-β-binding protein. J Biol Chem. 269:1994;6815-6821.
47. Olofsson A., Miyazono K., Kanzaki T., Colosetti P., Engstrom U., Heldin C.H. Transforming growth factor-β1, -β2, and -β3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem. 267:1992;19,482-19,488.
48. Moren A., Olofsson A., Stenman G., Sahlin P., Kanzaki T., Claesson-Welsh L., ten Dijke P., Miyazono K., Heldin C.H. Identification and characterization of LTBP-2, a novel latent transforming growth factor-β-binding protein. J Biol Chem. 269:1994;32,469-32,478.
49. Gibson M.A., Hatzinikolas G., Davis E.C., Baker E., Sutherland G.R., Mecham R.P. Bovine latent transforming growth factor β1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. Mol Cell Biol. 15:1995;6932-6942.
50. Yin W., Smiley E., Germiller J., Mecham R.P., Florer J.B., Wenstrup R.J., Bonadio J. Isolation of a novel latent transforming growth factor-β binding protein gene (LTBP-3). J Biol Chem. 270:1995;10,147-10,160.
51. Giltay R., Kostka G., Timpi R. Sequence and expression of a novel member (LTBP-4) of the family of latent transforming growth factor-β binding proteins. FEBS Lett. 411:1997;164-168.
52. Saharinen J., Taipale J., Monni O., Keski-Oja J. Identification and characterization of a new latent transforming growth factor-β-binding protein, LTBP-4. J Biol Chem. 273:1998;18,439-18,469.
53. Olofsson A., Hellman U., ten Dijke P., Grimsby S., Ichijo H., Moren A., Miyazono K., Heldin C.H. Latent transforming growth factor-β complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selection-ligand or MG-160. Biochem J. 324:1997;427-434.
54. Miyazono K., Olofsson A., Colosetti P., Heldin C.H. A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1. EMBO J. 10:1991;1091-1101.
55. Miyazono K., Thyberg J., Heldin C.H. Retention of the transforming growth factor-β1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form. J Biol Chem. 267:1992;5668-5675.
56. Taipale J., Saharinen J., Hedman K., Keski-Oja J. Latent transforming growth factor-β1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem. 44:1996;875-889.
57. Olofsson A., Ichijo H., Moren A., ten Dijke P., Miyazono K., Heldin C.H. Efficient association of an amino-terminally extended form of human latent transforming growth factor-β binding protein with the extracellular matrix. J Biol Chem. 270:1995;31,294-31,297.
58. Dallas S.L., Miyazono K., Skerry T.M., Mundy G.R., Bonewald L.F. Dual role for the latent transforming growth factor-β binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein. J Cell Biol. 131:1995;539-549.
59. Saharinen J., Taipale J., Keski-Oja J. Association of the small latent transforming growth factor-β with an eight cysteine repeat of its binding protein LTBP-1. EMBO J. 15:1996;245-253.
60. Tucker R., Shipley G., Moses H., Holley R. Growth inhibitor from BSC-1 cells closely related to platelet type-β transforming growth factor. Science. 226:1984;705-707.
61. Horimoto M., Kato J., Takimoto R., Terui T., Mogi Y., Niitsu Y. Identification of a transforming growth factor-β-1 activator derived from a human gastric cancer cell line. Br J Cancer. 72:1995;676-682.
62. Lawrence D., Pircher R., Jullien P. Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions. Biochem Biophys Res Commun. 133:1985;1026-1034.
63. Brown P., Wakefield L., Levinson A., Sporn M. Physicochemical activation of recombinant latent transforming growth factor-β's 1, 2 and 3. Growth Factors. 3:1990;35-43.
64. Lyons R., Keski-Oja J., Moses H. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol. 106:1988;1659-1665.
65. Lyons R., Gentry L.E., Purchio A.F., Moses H.L. Mechanism of activation of latent recombinant transforming growth factor-β1 by plasmin. J Cell Biol. 110:1990;1361-1367.
66. Abe M., Oda N., Sato Y. Cell-associated activation of latent transforming growth factor-β by calpain. J Cell Physiol. 174:1998;186-193.
67. Jullien P., Berg T., Lawrence D. Acidic cellular environments: activation of latent TGF-β and sensitization of cellular response to TGF-β and EGF. Int J Cancer. 43:1989;886-891.
68. Schultz-Cherry S., Murphy-Ullrich J. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J Cell Biol. 122:1993;923-932.
69. Schultz-Cherry S., Ribeiro S., Gentry L., Murphy-Ullrich J.E. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system. J Biol Chem. 269:1994;26,775-26,782.
70. Schultz-Cherry S., Lawler J., Murphy-Ullrich J.E. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β J Biol Chem. 269:1994;26,783-26,788.
71. Munger J., Huang X., Kawakatsu H., Griffiths M., Dalton S., Wu J., Pittet J-F., Kaminski N., Garat C., Matthay M., Rifkin D., Sheppard D. The integrin avβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 96:1999;319-328.
72. Barcellos-Hoff M., Dix T. Redox-mediated activation of latent transforming growth factor-β1. Mol Endocrinol. 10:1996;1077-1083.
73. Miyazono K., Heldin C. Role for carbohydrate structures in TGF-β1 latency. Nature. 338:1989;158-160.
74. Glick A., Flanders K., Danielpour D., Yuspa S., Sporn M. Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regul. 1:1989;87-97.
75. Koli K., Keski-Oja J. Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-β1 and β2 in cultured murine keratinocytes. Growth Factors. 8:1993;153-163.
76. Knabbe C., Lippman M., Wakefield L., Flanders K., Kasid A., Derynck R., Dickson R. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer. Cell. 48:1987;417-418.
77. Colletta A., Wakefield L., Howell F., van Roozendaal K., Danielpour D., Ebbs S., Sporn M., Baum M. Anti-oestrogens induce the secretion of active transforming growth factor-β from human fetal fibroblasts. Br J Cancer. 62:1990;405-409.
78. Oursler M., Riggs B., Spelsberg T. Glucocorticoid-induced activation of latent transforming growth factor-β by normal hormone osteoblast-like cell. Endocrinology. 133:1993;2187-2196.
79. Boulanger J., Reyes-Moreno C., Koutsilieris M. Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor-β1 in MG-63 human osteosarcoma cells. Int J Cancer. 61:1995;692-697.
80. Antonelli-Orlidge A., Saunders K., Smith S., D'Amore P. An activated form of transforming growth factor-β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA. 86:1989;4544-4548.
81. Sato Y., Rifkin D. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture. J Cell Biol. 109:1989;309-315.
82. Sato Y., Tsuboi R., Lyons R., Moses H., Rifkin D. Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol. 111:1990;757-763.
83. Huber D., Philipp J., Fontana A. Protease inhibitors interfere with the transforming growth factor-β-dependent but not the transforming growth factor-β-independent pathway of tumor cell-mediated immunosuppression. J Immunol. 148:1992;277-284.
84. Dennis P., Rifkin D. Cellular activation of latent transforming growth factor-β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA. 88:1991;580-584.
85. Kovacina K., Steele-Perkins G., Roth R. A role for the insulin-like growth factor II/mannose-6-phosphate receptor in the insulin-induced inhibition of protein catabolism. Mol Endocrinol. 3:1989;901-906.
86. Sato Y., Okada F., Abe M., Seguchi T., Kuwano M., Sato S., Furuya A., Hanai N., Tamaoki T. The mechanism for the activation of latent TGF-β during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-β to smooth muscle cells. J Cell Biol. 123:1993;1249-1254.
87. Lopez-Casillas F., Payne H.M., Andres J.L., Massague J. Betaglycan can act as a dual modulator of TGF-β access to signaling receptors: mapping of ligand binding and GAG attachment sites. J Cell Biol. 124:1994;557-568.
88. Lamarre J., Vasudevan J., Gonias S. Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-β complex from the cell surface. Biochem J. 302:1994;199-205.
89. Brauer P., Yee J. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor-β that can be activated by neural crest cell proteolysis. Dev Biol. 155:1993;281-285.
90. Carmeliet P., Schoonjans L., Kieckens L. Ream B., Degen J., Bronson R., De Vos R., van den Oord J., Collen D., Mulligan R. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 368:1994.
91. Bugge T., Suh T., Flick M., Daugherty C., Romer J., Solberg H., Ellis V., Dano K., Degen J. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem. 270:1995;16,886-16,894.
92. Murphy-Ullrich J., Schultz-Cherry S., Höök M. Transforming growth factor-β complexes with thrombospondin. Mol Biol Cell. 3:1992;181-188.
93. Yang Y., Dignam J., Gentry L. Role of carbohydrate structures in the binding of β1-latency-associated peptide to ligands. Biochemistry. 36:1997;11,923-11,932.
94. Schultz-Cherry S., Chen H., Mosher D., Misenheimer T., Krutzsch H., Roberts D., Murphy-Ullrich J. Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1. J Biol Chem. 270:1995;7304-7310.
95. Crawford S., Stellmach V., Murphy-Ullrich J., Ribeiro S., Lawler J., Hynes R., Boivin G., Bouck N. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell. 93:1998;1159-1170.
96. Arbeille B., Fauvel-Lafeve F., Lemesle M., Tenza D., Legrand Y. Thrombospondin: a component of microfibrils in various tissues. J Histochem Cytochem. 39:1991;1367-1375.
97. Aho S., Uitto J. Two hybrid analysis reveals multiple direct interactions for thrombospondin 1. Matrix Biol. 17:1998;401-412. in process citation.
98. 1. Mol Biol Cell. 9:1998;2627-2638.
99. 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J Cell Biol. 133:1996;921-928.
100. Ehrhart E., Segarini P., Tsang M., Carroll A., Barcellos-Hoff M. Latent transforming growth factor-β1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation. FASEB J. 11:1997;991-1002.
101. Burger A., Loffler H., Bamberg M., Rodemann H. Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol. 73:1998;401-408.
102. Barcellos-Hoff M., Derynck R., Tsang M., Weatherbee J. Transforming growth factor-β activation in irradiated murine mammary gland. J Clin Invest. 93:1994;892-899.
103. Flaumenhaft R., Abe M., Sato Y., Miyazono K., Harpel J., Heldin C.H., Rifkin D.B. Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J Cell Biol. 120:1993;995-1002.
104. Nunes I., Gleizes P.E., Metz C.N., Rifkin D.B. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β J Cell Biol. 136:1997;1151-1163.
105. Kojima S., Nara K., Rifkin D. Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Biol. 121:1993;439-448.
106. Nunes I., Shapiro R.L., Rifkin D.B. Characterization of latent TGF-β activation by murine peritoneal macrophages. J Immunol. 155:1995;1450-1459.
107. Laiho M., Saksela O., Andreasen P., Keski-Oja J. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β J Cell Biol. 106:1986;2403-2410.
108. Massague J. TGF-β signal transduction. Annu Rev Biochem. 67:1998;753-791.
109. Cheifetz S., Massague J. Isoform-specific transforming growth factor-β binding proteins with membrane attachments sensitive to phosphatidylinositol-specific phospholipase C. J Biol Chem. 266:1991;20,767-20,772.
110. Segarini P., Ziman J., Kane C., Dasch J. Two novel patterns of transforming growth factor-β (TGF-β) binding to cell surface proteins are dependent upon the binding of TGF-β1 and indicate a mechanism of positive cooperativity. J Biol Chem. 267:1992;1048-1053.
111. Butzow R., Fukushima D., Twardzik D., Ruoslahti E. A 60-kD protein mediates the binding of transforming growth factor-β to cell surface and extracellular matrix proteoglycans. J Cell Biol. 122:1993;721-727.
112. O'Connor-McCourt M., Wakefield L. Latent transforming growth factor-β in serum. A specific complex with alpha 2-macroglobulin. J Biol Chem. 262:1987;14,090-14,099.
113. Fava R., McClure D. Fibronectin-associated transforming growth factor. J Cell Biol. 131:1987;184-189.
114. Paralkar V., Vukicevic S., Reddi A. Transforming growth factor-β type 1 binds to collagen VI of basement membrane matrix: implications for development. Dev Biol. 143:1991;303-308.
115. Coffey R., Kost L., Lyons R., LaRusso N. Hepatic processing of transforming growth factor-β in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest. 80:1987;750-757.
116. Wakefield L., Winokur T., Hollands R., Christopherson K., Levinson A., Sporn M. Recombinant latent transforming growth factor-β1 has a longer plasma half-life in rats than active transforming growth factor-β1, and a different tissue distribution. J Clin Invest. 86:1990;1976-1984.
117. 2-macroglobulin. Role in transforming growth factor-β1 clearance. J Biol Chem. 266:1991;22,290-22,296.
118. Vukicevic S., Kleinman H., Luyten F., Roberts A., Roche N., Reddi A. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res. 202:1992;1-8.
119. Hildebrand A., Romaris M., Rasmussen L., Heinegard D., Twardzik D., Border W., Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor-β Biochem J. 302:1994;527-534.
120. Yamaguchi Y., Mann D., Ruoslahti E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature. 346:1990;281-284.
121. Border W., Noble N., Yamamoto T., Harper J., Yamaguchi Y., Pierschbacher M., Ruoslahti E. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature. 360:1992;361-364.
122. Takeuchi Y., Kodama Y., Matsumoto T. Bone matrix decorin binds transforming growth factor-β and enhances its bioactivity. J Biol Chem. 269:1994;32,634-32,638.
123. Wang X., Lin H., Ng-Eaton E., Downward J., Lodish H., Weinberg R. Expression cloning and characterization of the TGF-β type III receptor. Cell. 67:1991;797-805.
124. Cheifetz S., Bellon T., Cales C., Vera S., Bernabeu C., Massague J., Letarte M. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem. 267:1992;19,027-19,030.
125. St-Jacques S., Cymerman U., Pece N., Letarte M. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-β binding protein of endothelial and stromal cells. Endocrinology. 134:1994;2645-2657.
126. Miyazono K. TGF-β receptors and signal transduction. Int J Hematol. 65:1997;97-104.
127. Derynck R., Feng X. TGF-β receptor signaling. Biochem Biophys Acta. 1333:1997;F105-150.
128. Sankar S., Mahooti-Brooks N., Centrella M., McCarthy T., Madri J. Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor-β2. J Biol Chem. 270:1995;13,567-13,572.
129. Andres J.L., Stanley K., Cheifetz S., Massague J. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-β J Cell Biol. 109:1989;3137-3145.
130. Li C., Wilson P., Bernabeu C., Raab U., Wang J., Kumar S. Immunodetection and characterisation of soluble CD105-TGF-β complexes. J Immunol Methods. 218:1998;85-93.
131. McCaffrey T., Falcone D., Du B. Transforming growth factor-β1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-β1. J Cell Physiol. 152:1992;430-440.
132. Keski-Oja J., Lyons R., Moses H. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-β1. Cancer Res. 47:1987;6451-6458.
133. Piek E., Franzen P., Heldin C.H., ten Dijke P. Characterization of a 60-kDa cell surface-associated transforming growth factor-β binding protein that can interfere with transforming growth factor-β receptor binding. J Cell Physiol. 173:1997;447-459.
134. Fang J., Li X., Smiley E., Francke U., Mecham R.P., Bonadio J. Mouse latent TGF-β binding protein-2: molecular cloning and developmental expression. Biochim Biophys Acta. 1354:1997;219-230.
135. Rosenbloom J., Abrams W.R., Mecham R. Extracellular matrix 4: the elastic fiber. FASEB J. 7:1993;1208-1218.
136. Sakai L.Y., Keene D.R. Fibrillin: monomers and microfibrils. Methods Enzymol. 245:1994;29-52.
137. Reinhardt D.P., Chalberg S.C., Sakai L.Y. The structure and function of fibrillin. CIBA Found Symp. 192:1995;128-143.
138. Sakai L.Y., Keene D.R., Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol. 103:1986;2499-2509.
139. Maslen C.L., Corson G.M., Maddox B.K., Glanville R.W., Sakai L.Y. Partial sequence of a candidate gene for the Marfan syndrome. Nature. 352:1991;334-337.
140. Lee B., Godfrey M., Vitale E., Hori H., Mattei M.G., Sarfarazi M., Tsipouras P., Ramirez F., Hollister D.W. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature. 352:1991;330-334.
141. Zhang H., Apfelroth S.D., Hu W., Davis E.C., Sanguineti C., Bonadio J., Mecham R.P., Ramirez F. Structure and expression of fibrillin-2, a novel microfibrillar compound preferentially located in elastic matrices. J Cell Biol. 124:1994;855-863.
142. Cam Y., Lesot H., Colosetti P., Ruch J.V. Distribution of transforming growth factor-β1-binding proteins and low-affinity receptors during odontoblast differentiation in the mouse. Arch Oral Biol. 42:1997;385-391.
143. Cardy C.M., Handford P.A. Metal ion dependency of microfibrils supports a rod-like conformation for fibrillin-1 calcium-binding epidermal growth factor-like domains. J Mol Biol. 276:1998;855-860.
144. Gibson M., Hughes J., Fanning J., Cleary E. The major antigen of elastin-associated microfibrils is a 31-kDa glycoprotein. J Biol Chem. 261:1986;11,429-11,436.
145. Glanville R.W., Qian R.Q., McClure D.W., Maslen C.L. Calcium binding hydroxylation, and glycosylation of the precursor epidermal growth factor-like domains of fibrillin-1, the Marfan gene protein. J Biol Chem. 269:1994;26,630-26,634.
146. Handford P., Downing A.K., Rao Z., Hewett D.R., Sykes B.C., Kielty C.M. The calcium binding properties and molecular organization of epidermal growth factor-like domains in human fibrillin-1. J Biol Chem. 270:1995;6751-6756.
147. Downing A.K., Knott V., Werner J.M., Cardy C.M., Campbell I.D., Handford P.A. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell. 85:1996;597-605.
148. Reinhardt D.P., Ono R.N., Sakai L.Y. Calcium stabilizes fibrillin-1 against proteolytic degradation. J Biol Chem. 272:1997;1231-1236.
149. Reinhardt D.P., Mechling D.E., Boswell B.A., Keene D.R., Sakai L.Y., Bachinger H.P. Calcium determines the shape of fibrillin. J Biol Chem. 272:1997;7368-7373.
150. Yuan X., Downing A.K., Knott V., Handford P.A. Solution structure of the transforming growth factor-β-binding protein-like module, a domain associated with matrix fibrils. EMBO J. 16:1997;6659-6666.
151. Rebay I., Fleming R., Fehon R., Cherbas L., Cherbas P., Artavanis-Tsakonas S. Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell. 67:1991;687-699.
152. Adam S., Gohring W., Wiedemann H., Chu M.L., Timpl R., Kostka G. Binding of fibulin-1 to nidogen depends on its C-terminal globular domain and a specific array of calcium-binding epidermal growth factor-like (EG) modules. J Mol Biol. 272:1997;226-236.
153. Reinhardt D.P., Keene D.R., Corson G.M., Poschl E., Bachinger H.P., Gambee J.E., Sakai L.Y. Fibrillin-1: organization in microfibrils and structural properties. J Mol Biol. 258:1996;104-116.
154. Yuan X., Werner J.M., Knott V., Handford P.A., Campbell I.D., Downing K. Effects of proline cis-trans isomerization on TB domain secondary structure. Protein Sci. 7:1998;2127-2135.
155. Gleizes P.E., Beavis R.C., Mazzieri R., Shen B., Rifkin D.B. Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-β binding protein-1 that mediates bonding to the latent transforming growth factor-β1. J Biol Chem. 271:1996;29,891-29,896.
156. Hyytiäinen M., Taipale J., Heldin C.H., Keski-Oja J. Recombinant latent transforming growth factor-β-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J Biol Chem. 273:1998;20,669-20,676.
157. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 12:1996;697-715.
158. Kielty C.M., Whittaker S.P., Grant M.E., Shuttleworth C.A. Attachment of human vascular smooth muscles cells to intact microfibrillar assemblies of collagen VI and fibrillin. J Cell Sci. 103:1992;445-451.
159. Sakamoto H., Broekelmann T., Cheresh D.A., Ramirez F., Rosenbloom J., Mecham R.P. Cell-type specific recognition of RGD- and non-RGD-containing cell binding domains in fibrillin-1. J Biol Chem. 271:1996;4916-4922.
160. Pfaff M., Reinhardt D.P., Sakai L.Y., Timpl R. Cell adhesion and integrin binding to recombinant human fibrillin-1. FEBS Lett. 384:1996;247-250.
161. Ross J.M., McIntire L.V., Moake J.L., Kuo H.J., Qian R.Q., Glanville R.W., Schwartz E., Rand J.H. Fibrillin containing elastic microfibrils support platelet adhesion under dynamic shear conditions. Thrombosis & Haemostasis. 79:1998;155-161.
162. D'Arrigo C., Burl S., Withers A.P., Dobson H., Black C., Boxer M. TGF-β1-binding protein-like modules of fibrillin-1 and -2 mediate integrin-dependent cell adhesion. Connect Tissue Res. 37:1998;29-51.
163. Gibson M.A., Finnis M.L., Kumaratilake J.S., Cleary E.G. Microfibril-associated glycoprotein-2 (MAGP-2) is specifically associated with fibrillin-containing microfibrils but exhibits more restricted patterns of tissue localization and developmental expression than its structural relative MAGP-1. J Histochem Cytochem. 46:1998;871-886.
164. Kanzaki T., Shiina R., Saito Y., Oohashi H., Morisaki N. Role of latent TGF-β1 binding protein in vascular remodeling. Biochem Biophys Res Commun. 246:1998;26-30.
165. Corson G.M., Chalberg S.C., Dietz H.C., Charbonneau N.L., Sakai L.Y. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end. Genomics. 17:1993;476-484.
166. Lonnqvist L., Reinhardt D., Sakai L., Peltonen L. Evidence for furin-type activity-mediated C-terminal processing of profibrillin-1 and interference in the processing by certain mutations. Hum Mol Genet. 7:1998;2039-2044. [in process citation].
167. Michel K., Roth S., Trautwein C., Gong W., Flemming P., Gressner A.M. Analysis of the expression pattern of the latent transforming growth factor-β binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region. Hepatology. 27:1998;1592-1599.
168. Öklu R., Metcalfe J., Hesketh T., Kemp P. Loss of a consensus heparin binding site by alternative splicing of latent transforming growth factor-β binding protein-1. FEBS Lett. 425:1998;281-285.
169. Yin W., Smiley E., Bonadio J. Alternative splicing of LTBP-3. Biochem Biophys Res Commun. 245:1998;454-458.
170. Keene D., Maddox B.K., Kuo H.J., Sakai L.Y., Glanville R.W. Extraction of extendable beaded structures and their identification as fibrillin-containing extracellular matrix microfibrils. J Histochem Cytochem. 39:1991;441-449.
171. Saharinen J., Hyytiäinen M., Taipale J., Keski-Oja J. Latent TGF-β complexes in the extracellular matrix with 8-Cys containing proteins: characterization of the 3rd 8-Cys repeat of LTBP-1. Mol Biol Cell. 7:(suppl. 414a):1996;2406.
172. Pereira L., Andrikopoulos K., Tian J., Lee S.Y., Keene D.R., Ono R., Reinhardt D.P., Sakai L.Y., Biery N.J., Bunton T., Dietz H.C., Ramirez F. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet. 17:1997;218-222.
173. Zhang H., Hu W., Ramirez F. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol. 129:1995;1165-1176.
174. Flanders K., Thompson N., Cissel D., Van Obberghen-Schilling E., Baker C., Kass M., Ellingsworth L., Roberts A., Sporn M. Transforming growth factor-β1: histochemical localization with antibodies to different epitopes. J Cell Biol. 108:1989;653-660.
175. Reber-Muller S., Spissinger T., Schuchert P., Spring J., Schmid V. An extracellular matrix protein of jellyfish homologous to mammalian fibrillins forms different fibrils depending on the life stage of the animal. Dev Biol. 169:1995;662-672.
176. Child A.H. Marfan syndrome - current medical and genetic knowledge: how to treat and when. J Card Surg. 12:1997;131-135. discussion 135-136.
177. Ramirez F. Fibrillin mutation in Marfan syndrome and related phenotypes. Curr Opin Genet Dev. 6:1996;309-315.
178. Green M., Sweet H., Bunker L. Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am J Pathol. 82:1976;493-512.
179. Siracusa L.D., McGrath R., Ma Q., Moskow J.J., Manne J., Christner P.J., Buchberg A.M., Jimenez S.A. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res. 6:1996;300-313.
180. Kielty C.M., Raghunath M., Siracusa L.D., Sherratt M.J., Peters R., Shuttleworth C.A., Jimenez S.A. The tight skin mouse: demonstration of mutant fibrillin-1 production and assembly into abnormal microfibrils. J Cell Biol. 140:1998;1159-1166.
181. Kainulainen K., Karttunen L., Puhakka L., Sakai L., Peltonen L. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat Genet. 6:1994;64-69.
182. Sood S., Eldadah Z.A., Krause W.L., McIntosh I., Dietz H.C. Mutation in fibrillin-1 and the Marfanoid craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet. 12:1996;209-211.
183. Wirtz M.K., Samples J.R., Kramer P.L., Rust K., Yount J., Acott T.S., Koler R.D., Cisler J., Jahed A., Gorlin R.J., Godfrey M. Weill-Marchesani syndrome - possible linkage of the autosomal dominant form to 15q21.1. Am J Med Genet. 65:1996;68-75.
184. Milewicz D.M., Grossfield J., Cao S.N., Kielty C., Covitz W., Jewett T.A. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest. 95:1995;2373-2378.
185. Tan F.K., Stivers D.N., Foster M.W., Chakraborty R., Howard R.F., Milewicz D.M., Arnett F.C. Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a native American population. Arthritis Rheum. 41:1998;1729-1737.
186. Shipley J.M., et al. Latent TGF-β binding protein-2 is required for normal mouse development. Am Resp Crit Care Med. 157:1998;A246.
187. Mathews K.R., Godfrey M. Marfan like phenotypes caused by mutations in LTBP-2. Am J Hum Genet. 61:(suppl):1997;A44.
188. Chuaqui R., Zhuang Z., Emmert-Buck M., Liotta L., Merino M. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol. 150:1997;297-303.
189. Waltenberger J., Wanders A., Fellstrom B., Miyazono K., Heldin C.H., Funa K. Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol. 151:1993;1147-1157.
190. Waltenberger J., Lundin L., Oberg K., Wilander E., Miyazono K., Heldin C.H., Funa K. Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol. 142:1993;71-78.
191. Maeda J., Ueki N., Ohkawa T., Iwahashi N., Nakano T., Hada T., Higashino K. Local production and localization of transforming growth factor-β in tuberculous pleurisy. Clinical & Experimental Immunology. 92:1993;32-38.
192. Karonen T., Jeskanen L., Keski-Oja J. Transforming growth factor-β1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma. Br J Dermatol. 137:1997;51-58.
193. Raghunath M., Unsold C., Kubitscheck U., Bruckner-Tuderman L., Peters R., Meuli M. The cutaneous microfibrillar apparatus contains latent transforming growth factor-β binding protein-1 (LTBP-1) and is a repository for latent TGF-β1. J Invest Dermatol. 111:1998;559-565.
194. Eklov S., Funa K., Nordgren H., Olofsson A., Kanzaki T., Miyazono K., Nilsson S. Lack of the latent transforming growth factor-β binding protein in malignant, but not benign prostatic tissue. Cancer Res. 53:1993;3193-3197.
195. Mizoi T., Ohtani H., Matsuno S., Nagura H. Immunohistochemical identification of transforming growth factor-β and its binding protein in human gastrointestinal carcinoma. Tohoku J Exp Med. 168:1992;271-273.
196. Mizoi T., Ohtani H., Miyazono K., Miyazawa M., Matsuno S., Nagura H. Immunoelectron microscopic localization of transforming growth factor-β1 and latent transforming growth factor-β1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res. 53:1993;183-190.
197. Barcellos-Hoff M. Radiation-induced transforming growth factor-β and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res. 53:1993;3880-3886.
198. Stenman G., Sahlin P., Olofsson A., Geurtz van Kessel A., Miyazono K. Assignment of the gene encoding the latent TGF-β1-binding protein (LTBP1) to human chromosome 2, region p12→q22. Cytogenet Cell Genet. 66:1994;117-119.
199. Li X., Yin W., Perez-Jurado L., Bonadio J., Francke U. Mapping of human and murine genes for latent TGF-β binding protein-2 (LTBP2). Mamm Genome. 6:1995;42-45.
200. Gong W., Roth S., Michel K., Gressner A.M. Isoforms and splice variant of transforming growth factor β-binding protein in rat hepatic stellate cells. Gastroenterology. 114:1998;352-363.
201. Oklu R., Hesketh T., Metcalfe J., Kemp P. Expression of alternatively spliced human latent transforming growth factor-β binding protein-1. FEBS Lett. 435:1998;143-148.
202. Krohn K. TGF-dependent expression of a rat LTBP-2 homologue in astrocytes and C6 glioma cells. Genbank sequence entry, Accession number Y12760. 1997.
203. Pereira L.M.D.A., Ramirez F., Lynch J.R., Sykes B., Pangilinan T., Bonadio J. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet. 2:1993;961-968. [published erratum appears in Hum Mol Genet 1993:1762].
204. Koski C., Saharinen J., Keski-Oja J. Independent promoters regulate the expression of two amino terminally distinct forms of latent TGF-β binding protein-1 (LTBP-1). 1999;. (submitted for publication).
205. Saharinen J., Koski C., Keski-Oja J. Molecular cloning of the human LTBP-3 protein. 1999;. (submitted for publication).
206. Dallas S, Keene D, Bruder S, Saharinen J, Sakai L, Mundy G, Bonewald L. Localization of the latent TGF-β binding protein-1 (LTBP-1) to fibrillin-containing microfibrils in bone cells in vitro and in vivo. J Bone Miner Res 1999 (in press).
207. Saharinen J, Keski-Oja J. Structural analysis of the transforming growth factor-β binding and non-binding types of 8-cysteine repeats in latent transforming growth factor binding proteins 1-4 and fibrillin-1. 1999 (submitted for publication).